Catalina Capital Group LLC Acquires Shares of 1,481 Agilent Technologies, Inc. (NYSE:A)

Catalina Capital Group LLC bought a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 1,481 shares of the medical research company’s stock, valued at approximately $220,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Crewe Advisors LLC lifted its stake in Agilent Technologies by 114.8% in the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after acquiring an additional 101 shares during the period. Livelsberger Financial Advisory bought a new stake in shares of Agilent Technologies in the 3rd quarter valued at about $28,000. Ridgewood Investments LLC purchased a new stake in shares of Agilent Technologies in the 2nd quarter worth approximately $29,000. Fortitude Family Office LLC boosted its stake in shares of Agilent Technologies by 68.3% during the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock valued at $35,000 after purchasing an additional 95 shares in the last quarter. Finally, Ashton Thomas Private Wealth LLC bought a new position in shares of Agilent Technologies during the second quarter valued at approximately $39,000.

Insider Activity at Agilent Technologies

In other news, SVP Dominique Grau sold 9,990 shares of the company’s stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at $5,801,595. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. In other news, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the sale, the chief executive officer now owns 24,118 shares of the company’s stock, valued at $3,497,110. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Dominique Grau sold 9,990 shares of the company’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the sale, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 11,995 shares of company stock worth $1,739,510 in the last three months.

Agilent Technologies Stock Performance

Shares of A stock opened at $139.63 on Friday. The business has a fifty day moving average of $139.64 and a 200 day moving average of $138.18. Agilent Technologies, Inc. has a 1 year low of $104.09 and a 1 year high of $155.35. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. The firm has a market capitalization of $40.12 billion, a price-to-earnings ratio of 28.97, a price-to-earnings-growth ratio of 6.14 and a beta of 1.07.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the previous year, the company posted $1.43 earnings per share. The company’s revenue was down 5.6% compared to the same quarter last year. As a group, research analysts expect that Agilent Technologies, Inc. will post 5.24 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were issued a dividend of $0.236 per share. This represents a $0.94 annualized dividend and a dividend yield of 0.68%. The ex-dividend date of this dividend was Tuesday, October 1st. Agilent Technologies’s dividend payout ratio (DPR) is 19.50%.

Wall Street Analysts Forecast Growth

A has been the subject of a number of analyst reports. Stifel Nicolaus restated a “buy” rating and set a $151.00 target price on shares of Agilent Technologies in a report on Monday, August 26th. Bank of America upped their price objective on Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. Wells Fargo & Company began coverage on Agilent Technologies in a research note on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 target price on the stock. Evercore ISI increased their price target on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Finally, Barclays raised their price target on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “underweight” rating in a report on Tuesday, October 15th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $144.36.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.